- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Progressive CNS malignancies
Total 9304 results
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Centre Hospitalier de PAUUniversity Hospital, BordeauxCompletedNervous System Diseases | Multiple Sclerosis, Chronic ProgressiveFrance
-
VA Office of Research and DevelopmentCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedHematological Malignancies | Malignant Melanoma | Tumors | Leukemia, Lymphoblastic, Acute | Myelogenous Leukemia, ChronicUnited States
-
University of UtahMallinckrodtTerminatedOpen-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis (MSECP)Secondary Progressive Multiple SclerosisUnited States
-
Dimitrios KarussisCompletedMultiple Sclerosis (MS)Israel
-
Children's Hospital Medical Center, CincinnatiAlex's Lemonade Stand FoundationCompleted
-
Eli Lilly and CompanyCompletedAlzheimer DiseaseUnited States
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid... and other conditionsUnited States
-
University of Massachusetts, LowellOhio State UniversityCompletedHemiparesis | Primary Progressive Multiple SclerosisUnited States
-
BayerCompleted
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedPrimary Progressive Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
AB ScienceCompleted
-
Avid RadiopharmaceuticalsEli Lilly and Company; PRA Health SciencesCompletedAlzheimer Disease | Cognition DisordersUnited States
-
Kiromic, Inc.WithdrawnCancer | Hematologic Malignancies
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
Terry L. WahlsCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
BayerCompleted
-
University Hospital, Clermont-FerrandMedDay Pharmaceuticals SA; OFSEP (Observatoire Français de la Sclérose en Plaques) and other collaboratorsUnknownProgressive Multiple SclerosisFrance
-
M.D. Anderson Cancer CenterTerminatedLeukemia | Metastatic Malignant Neoplasm to the Leptomeninges | Lymphoid MalignanciesUnited States
-
American CryoStem CorporationTerminatedMultiple SclerosisCayman Islands
-
AbbVieCompletedMultiple SclerosisUnited States
-
National Cancer Institute (NCI)TerminatedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemias | Multiple Myeloma With PlasmacytomaUnited States
-
Multiple Sclerosis Center of Northeastern New YorkIcahn School of Medicine at Mount Sinai; BiogenUnknownMultiple SclerosisUnited States
-
TauRx Therapeutics LtdCompletedBehavioral Variant Frontotemporal Dementia (bvFTD)United States, Australia, Canada, Croatia, Poland, Netherlands, United Kingdom, Spain, Germany, Italy, Romania, Singapore
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
European Organisation for Research and Treatment...CompletedCancerBelgium, Switzerland, Italy, France, Germany
-
University of MiamiNational Multiple Sclerosis Society; CerecinCompletedRelapsing Remitting MS | Secondary Progressive MS | Primary Progressive MSUnited States
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Universitätsklinikum Hamburg-EppendorfDeutsche Multiple Sklerose Gesellschaft HamburgUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHIV Infection | Unspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal... and other conditionsUnited States
-
Universitätsklinikum Hamburg-EppendorfUnknownMultiple Sclerosis, Chronic Progressive
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
Vanderbilt UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative Neoplasms | MethemoglobinemiaUnited States
-
MedDay Pharmaceuticals SAUnknownMultiple SclerosisUnited Kingdom, France
-
MedDay Pharmaceuticals SAUnknown
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
VA Office of Research and DevelopmentOregon Health and Science UniversityCompletedMultiple Sclerosis, Chronic ProgressiveUnited States